Axis Direct is bullish on Oberoi Realty has recommended buy rating on the stock with a target price of Rs 471 in its research report dated October 03, 2017.
Axis Direct's research report on Oberoi Realty
Oberoi Realty is to buy GSK Pharma’s 60 acre land parcel at Thane for Rs 5.5 bn. The deal is in line with company’s strategy of continued focus on the Mumbai Metropolitan Region (MMR). Adding a new micro-market to the portfolio will boost sales traction FY19 onwards. While we await further clarity on the transaction, our preliminary analysis suggests the project can add ~Rs 56/ share of value.
Our revised TP stands at Rs 471 (vs. Rs 415 earlier). Upgrade to BUY (from HOLD earlier).
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.